Kelly Yap, M.D.
"It is a great privilege and honor to be there to guide patients in their journey of healing."
Kelly Yap, M.D. is passionate about all the advances being made in the rapidly-changing field of medical oncology. She's excited to be able to offer her patients the latest personalized treatments which are more effective while causing fewer side effects. She makes it a priority to build relationships with her patients while guiding them through the complexity of cancer care.
2016, American Board of Internal Medicine, Medical Oncology
2016, American Board of Internal Medicine, Hematology
2013, American Board of Internal Medicine, Internal Medicine
2006, M.B., B. Ch., B.A.O. with honors, Queen’s University of Belfast, Northern Ireland, UK
2013-2016, Fellowship, Hematology/Oncology, LAC/USC Medical Center, Los Angeles, California
2012-2013, Chief Resident, Internal Medicine, York Hospital, York, Pennsylvania
2010-2013, Residency, Internal Medicine, York Hospital, York, Pennsylvania
2019-present, Assistant Clinical Professor, Department of Medical Oncology and Therapeutics Research, City of Hope, South Pasadena and Arcadia, California
2016-2018, Assistant Professor of Clinical Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California
2011, Intern of The Year
2006, Medical Distinction Prize
2004, Foundation Scholarship
2004, Musgrave Prize in Pathology
2003, Milroy Medal in Physiology
2003, Henry Hutchinson Stewart Scholarship
2016, American Association for Cancer Research
2011, American Society of Clinical Oncology
American Society of Clinical Oncology (ASCO)
American Association for Cancer Research (AACR)
Yap KKL, Koc M, Lu JM, Spicer DV. Is there a role for 21-gene recurrence score in mucinous carcinoma of breast? J Clin Oncol 36, 2018 (suppl 15; abstr e12538)
Yap KKL, Tripathy D. A review of the management of T1a/bN0 HER2-overexpressed breast cancer. American Journal of Hematology and Oncology, December 2014.
Yap KKL, Kannarkatt JT, McCormick TC, Efiom-Ekaha D. Ovarian and thyroid metastases from renal cell carcinoma successfully treated with metastectomy. 11th International Kidney Cancer Symposium Poster Presentation, November 2012, Chicago, IL.
Yap KKL, Efiom-Ekaha D. Does younger women with early breast cancer have a higher recurrence risk? J Clin Oncol 29, 2011 (suppl 27; abstr 178)
Yap KKL, Efiom-Ekaha D. Is obesity associated with increased recurrence risk in estrogen receptor (ER)- positive breast cancer? J Clin Oncol 29, 2011 (suppl 27; abstr 171)
Yap KKL, Efiom-Ekaha D. Is Modified Bloom-Richardson (MBR) grade a reliable predictor of breast cancer recurrence? J Clin Oncol 29, 2011 (suppl 27; abstr 52)